Nanalysis Scientific Corp. (TSXV: NSCI)

Market Cap	36.76M
Revenue (ttm)	43.01M
Net Income (ttm)	-8.28M
Shares Out	113.10M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,500
Average Volume	42,631
Open	0.330
Previous Close	0.325
Day's Range	0.300 - 0.330
52-Week Range	0.250 - 0.600
Beta	0.64
RSI	49.90
Earnings Date	Apr 30, 2025

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60 MHz and 100 MHz NMR platform; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides and software products, such as NMRGui...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NSCI

Financial Performance

In 2023, Nanalysis Scientific's revenue was 28.47 million, an increase of 14.69% compared to the previous year's 24.82 million. Losses were -16.20 million, 78.0% more than in 2022.